rubraca 200 mg
neopharm ltd, israel - rucaparib as camsylate - film coated tablets - rucaparib as camsylate 200 mg - rucaparib - for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube,or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy
rubraca 250 mg
neopharm ltd, israel - rucaparib as camsylate - film coated tablets - rucaparib as camsylate 250 mg - rucaparib - for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube,or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy
rubraca 300 mg
neopharm ltd, israel - rucaparib as camsylate - film coated tablets - rucaparib as camsylate 300 mg - rucaparib - for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube,or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy
venclexta 10 mg film-coated tablet
abbvie inc. - venetoclax - film-coated tablet - 10 mg
venclexta 50 mg film-coated tablet
abbvie inc. - venetoclax - film-coated tablet - 50 mg
venclexta 100 mg film-coated tablet
abbvie inc., united states - venetoclax - film-coated tablet - 100 mg
venclexta 10 mg / 50 mg / 100 mg film-coated tablet
abbvie inc., united states - venetoclax - film-coated tablet - 10, 50, 100 mg
lynparza 50 mg capsule capsule, hard
astrazeneca ab - olaparib - capsule, hard - 50 mg
kyprolis 60 mg powder for solution for injection
onyx pharmaceuticals inc. - carfilzomib - powder for solution for injection - 60 mg
kyprolis 60 mg powder for solution for injection
onyx pharmaceuticals inc., united states - carfilzomib - powder for solution for injection - 60 mg